Chemical Compound
Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide; GW 786034; Pazopanib; Votrient
CAS Registry Number
444731-52-6
Primary record
Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide; GW 786034; Pazopanib; Votrient
- 库存
- 1,263 克
- 纯度
- 98.3 %
- CAS
- 444731-52-6
化合物标识与属性
- CAS
- 444731-52-6
- PubChem CID
- 10113978
- SMILES
- CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
- Canonical SMILES
- Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O
名称与同义词
- Pazopanib
- Votrient
- 444731-52-6
- pazopanibum
- pazopanib HCl
- Pazopanib?
- Pazopanib [INN]
- Pazopanib-d6
- Pazopanib hydrochloride
- Pazopanib [INN:BAN]
- Pazopanib (Standard)
- GW786034
- indazolylpyrimidine 13
- Pazopanib (free base)
- 7RN5DR86CK
- Kinome_3790
- RefChem:55812
- UNII-7RN5DR86CK
- PAZOPANIB [MI]
- Pazopanib (GW-786034)
- PAZOPANIB [VANDF]
- DTXSID8048733
- MFCD11616589
- Pazopanib(GW786034)
- Pazopanib/GW-786034
- PAZOPANIB [WHO-DD]
- DTXCID1028659
- PAZOPANIB [EMA EPAR]
- C21H23N7O2S
- CHEBI:71219
- HSDB 8210
- NSC-752782
- SCHEMBL588608
- Pazopanib - Bio-X trade mark
- CHEMBL477772
- GTPL5698
- GW-786034
- JMC514632 Compound 13
- orb1310940
- SCHEMBL29392503
- BDBM26474
- GW 786034
- QCR-110
- SYN1058
- cid_10113978
- CUIHSIWYWATEQL-UHFFFAOYSA-N
- GW786034B
- BCPP000129
- GLXC-90392
- GW 78603
- GW780604
- HMS3244C21
- HMS3244C22
- HMS3244D21
- HMS3656L14
- HMS3745G05
- HMS5081I04
- GW 786034B
- GW-786034B
- AOB87179
- BCP01839
- EX-A1241
- GW-780604
- Tox21_113174
- ABP000868
- ABP000882
- AN-050
- EBC-12617
- HY-10208R
- NCGC00188865-01
- NP3712
- NSC752782
- NSC800839
- RS0094
- s3012
- ZINC11617039
- AKOS005145819
- Tox21_113174_1
- 5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide
- AC-8522
- ACN-034472
- BCP9001053
- CCG-265010
- CS-0269
- DB06589
- FD26771
- NSC 752782
- NSC-800839
- SB17290
- SDCCGSBI-0647656.P002
- 790713-33-6
- CID10113978
- NCGC00188865-02
- NCGC00188865-03
- NCGC00188865-10
- AS-11066
- BC280878
- BD164238
- BP-44038
- CID:10113978
- HY-10208
- SC-23290
- SY067128
- SID:134223208
- 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide
- AB0008634
- AB1008452
- GW 780604
- GW7 86034
- A3022
- AM20090659
- CAS-444731-52-6
- FT-0659928
- FT-0684794
- NS00070516
- ST24031511
- SW218082-3
- EN300-57325
- J2.417.435B
- Pazopanib Hydrochloride /GW786034,VOTRIENT
- 5-[4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino]-2-methyl-benzenesulfonamide
- A11518
- A19406
- P-6706
- Q-1426
- S-7750
- SBI-0647656.0001
- AB01273967-01
- AB01273967-02
- AB01273967_05
- AB01273967_06
- A839572
- AR-270/43507999
- C516667
- 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
- I09-0358
- Q7157043
- BRD-K74514084-001-03-9
- BRD-K74514084-003-02-7
- BRD-K74514084-003-09-2
- 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide
- Z1541638525
- 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
- 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide
- 5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide
- 635702-64-6
- Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-
- 5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide
- 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide
- 1219592-01-4
- 2-Methyl-5-[[4-[methyl(2,3-dimethyl-2H-indazole-6-yl)amino]pyrimidine-2-yl]amino]benzenesulfonamide
- 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide
- 5-({4-[(2,3-dimethylindazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide
- 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide
- 5-[[4-[2,3-Dimethyl-2H-indazole-6-yl(methyl)amino]pyrimidine-2-yl]amino]-2-methylbenzenesulfonamide
- Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide; GW 786034; Pazopanib; Votrient
- Benzenesulfonamide,5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-
- N4(2,3-dimethyl-2H-indazol-6-yl)-N4-methyl-N2-(4-methyl-3-sulfonamidophenyl)-2,4-pyrimidinediamine